This study compared the safety and immunogenicity profiles of MF@-adjuvanted , trivalent , influenza vaccine ( ATIV ) and non-adjuvanted , trivalent , influenza vaccine ( TIV ) in Guatemalan children ( N = @ ) between @ and < @ months of age .